Participants 181 291 4
patients with functional dyspepsia, supporting the use of prokinetic drugs for treatment of dyspeptic symptoms
Participants 367 487 8
1298 patients were enrolled in a double-blind multicentric study carried out in 45 Italian Gastroenterology Departments.
Participants 648 1113 4
Patients were selected on the basis of: a) occurrence in the last 4 weeks of at least 5/10 selected symptoms (anorexia, nausea, vomiting, upper abdominal pain, postprandial bloating, abdominal fullness, early satiety, belching, heartburn, regurgitation), severity of which should reach/exceed a total score of 8, as assessed by a specific scale ranging from 0 (absent) to 3 (severe); b) normal results of routine biochemical, ultrasound and endoscopic examinations.
